Effects of selenium supplementation on paraoxonase-1 and myeloperoxidase activity in subjects with cardiovascular disease: the Selenegene study, a double-blind randomized controlled trial

INTRODUCTION: We previously highlighted the potential link between supplementation with selenium, as an antioxidant trace element, and changes in the levels of paraoxonase (POX1) and myeloperoxidase (MPO), as an antioxidant enzyme, in patients with documented cardiovascular disease (CVD). The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirmohammadsadeghi, Amirhossein, Gharipour, Mojgan, Roohafza, Hamidreza, Dianatkhah, Minoo, Sadeghi, Masoumeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374566/
https://www.ncbi.nlm.nih.gov/pubmed/30775600
http://dx.doi.org/10.5114/amsad.2018.77820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374566/
https://www.ncbi.nlm.nih.gov/pubmed/30775600
http://dx.doi.org/10.5114/amsad.2018.77820

Ejemplares similares